期刊文献+

融合蛋白弓形虫主要表面抗原P30-CTXA2/B在大肠杆菌中的表达

Express of toxoplasma major surface antigen P30 fusion protein with cholera toxin A2/B in bacillus coli
下载PDF
导出
摘要 目的 :克隆并表达含有刚地弓形虫主要表面抗原P30及霍乱毒素A2 /B亚基基因的原核表达载体 ,为弓形虫疫苗的研究奠定基础。方法 :通过PCR方法扩增出P30基因片段 ,将其克隆入含有霍乱毒素A2 /B亚基基因的表达质粒pUAB0 2 4 ,在大肠杆菌JM10 9(DE3)中表达融合蛋白。行SDS PAGE电泳及West ernblotting检测鉴定。结果 :酶切电泳证明质粒构建正确。SDS PAGE显示IPTG诱导可以产生特异性条带。Westernblotting进一步证实该条带为p30 CTA2 /B融合蛋白。结论 :成功构建的表达载体pUAB0 2 4 p30可有效表达特异性的融合抗原蛋白P30 CTA2 /B。 Objective:To construct Prokaryotic expression plasmid containing major surface antigen P30 of toxoplasma gondii and cholera toxin A 2/B subunit gene to express fusion protein. Methods: P30 gene. Fragment was Obtained by PCR and inserted into express plasmid PUAB024 which contains cholera toxin A2/B subunit gene. Fusion protein was expressed in JM109(DE3) and SDS-PAGE and Western blot were adopted for detection and appraisal. Results: Correct construction of express plasmid was proved by SDS-PAGE,which showed that specific band could be produced through IPTG induction.The band was further verified by western blotting as fussion: protein P30-CTA2/B. Conclusion: Prokaryotic express plasmid PUAB024 was successfully constructed and the fusion protein P30-CTA2/B was specifically expressed.
出处 《山东大学学报(医学版)》 CAS 2002年第3期210-212,共3页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助项目 (Y99C0 2 )
关键词 弓形虫属 霍乱毒素 基因表达 大肠杆菌 Toxoplasma Cholera toxin Gene expression Escherichia coli
  • 相关文献

参考文献2

二级参考文献35

  • 1金冬雁(译),分子克隆实验指南(第2版),1992年
  • 2马清钧,微生物学报,1988年,28卷,4期,307页
  • 31.Williams NA, Hirst TR, Nashar TO.Immune modulation by the cholera? likeenterotoxins: from adjuvant to therapeutic. Immunol Today,1999,20(2):95
  • 42.Nashar TO, Williams NA, Hirst TR. Importance of receptor binding in the imm unogenicity,adjuvanticity and therapeutic properties of cholera toxin and Escherichia coli heat?labileenterotoxin. Med Microbiol Immunol (Ber l),1998,187(1):3
  • 53.Lencer WI, Hirst TR, Holmes RK. Membrane traffic and the cellular uptake of choleratoxin. Biochim Biophys Acta,1999,8;1450(3):177
  • 64.Hovey BT, Verlinde CL, Merritt EA et al. Structure?based d iscovery of a pore?bindingligand: towards assembly inhibitors for cholera and related AB5 toxins. J Mol Biol,1999,285(3):1169
  • 75.Cheng E, Cardenas?Freytag L, Clements JD.The role of cAMP in mucosal adjuv anticity ofEscherichia coli heat?labile enterotoxin (LT). Vacc ine,1999,18(1?2):38
  • 86.Glenn GM, Scharton?Kersten T, Vassell R et al. Transcutane ous immunization withbacterial ADP?ribosylating exotoxins as antigens and adju vants. Infect Immun,1999,67(3):1100
  • 97.Rappuoli R, Pizza M, Douce G et al. Structure and mucosal a djuvanticity of cholera andEscherichia coli heat?labile entero toxins. Immunol Today,1999,20(11):493
  • 108.Cong Y, Bowdon HR, Elson CO. Identification of an immunodominant T cell epi tope oncholera toxin. Eur J Immunol,1996,26(11):2587

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部